At that level they are trading at 39.68% premium to the analyst consensus target price of 0.00. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. View real-time stock prices and stock quotes for a full financial overview. Analysts covering Pacific Biosciences of California Inc currently have a consensus Earnings Per Share (EPS) forecast of … Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and … Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, IRS says this tax season will be ‘one of the nation’s most important.’ Watch out for these key dates, Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5, Illumina, Pacific Biosciences drop $1.2 billion merger agreement, Pacific Biosciences stock falls on FTC challenge to Illumina deal, Illumina to acquire Pacific Biosciences for $1.2 billion in cash, U.S. benchmarks survive important technical tests, U.S. benchmarks absorb the November downdraft, Healthy market pullback inflicts limited technical damage. Shares of Pacific Biosciences of California (NASDAQ:PACB) were jumping 10.6% as of 3:15 p.m. EDT on Friday. Intraday Data provided by FACTSET and subject to terms of use. Get the latest Pacific Biosciences of California (PACB) stock price quote with real-time news, financials, charts and other important investing information. Product revenues were $77.7 million (85.5% of net revenues), while Service revenues totaled $13.1 million (14.5%). In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. A Director at Pacific Biosciences (PACB) is Selling Shares. Pacific Biosciences’ 2019 revenues totaled $77.7 million. Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.57, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 50.62. The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)? Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. It operates through the following geographical segments: North America, Europe, and Asia Pacific. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Hewlett-Packard, Oracle, Alpha Natural Resources. Privacy Notice, and [failed verification] PacBio describes its platform as single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Quick Links Shares in Pacific Biosciences of California Inc are currently priced at $38.59. Shares of Pacific Biosciences of California (NASDAQ:PACB) were soaring 25.6% as of 11:54 a.m. EDT on Wednesday. Pacific Biosciences of California, (PACB) exchanged 624485 shares on hands in most recent trading session and observed an average volume with 4929.48K shares. Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss, Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates, Medical Products Earnings Due on Nov 2: STE, HSIC & More. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Pacific Biosciences … The shares were sold at an average price of $37.53, for a total transaction of $23,433,882.12. Wednesday’s biggest gaining and declining stocks, Why You Should Retain Pacific Biosciences (PACB) Stock Now, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021, 7 5G ETFs Sit On The Cusp of a Tech Revolution Ready to Explode in 2021, Top ETF of December & Its Best Stocks, Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Quidel (QDEL) to Report Q3 Earnings: What's in the Cards? Historical and current end-of-day data provided by FACTSET. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. The stock's open price was 38.59. Cookie Notice. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Michael Hunkapiller sold 624,404 shares of the company's stock in a transaction dated Friday, January 22nd. Pacific Biosciences (PACB) Stock Is Very Extended...PACB. The Price to Book ratio for the last quarter was 26.79, with the Price … Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. © 2021 Verizon Media. Post-Market 0.24 (0.66%) Log in to see them here or sign up to get started. Subscribe to Premium to view Fair Value for PACB. Something went wrong while loading Watchlist. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Copyright © 2021 MarketWatch, Inc. All rights reserved. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. The company’s stock price has collected 16.25% of gains in the last five trading sessions. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. The question now for investors is whether that price strength will continue. Intraday data delayed at least 15 minutes or per exchange requirements. CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today. "This is another great stock," Jim Cramer told viewers of the Lightning Round segment of Mad Money Tuesday evening when asked about Pacific Biosciences of California Inc. . In comparing Pacific Biosciences of California, Inc. (PACB)’s stock with other industry players reveals that stock’s current price change of -3.33% and that of +271.75% over the past 12 months is in competing position with that of Thermo Fisher Scientific Inc (TMO) which saw its stock price raised by 1.56% in the last trading and went through an increase of 45.48% in past 12-month trading. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. Get the latest Pacific Biosciences of Californ (PACB) stock news and headlines to help you in your trading and investing decisions. Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Visit a quote page and your recently viewed tickers will be displayed here. This browser is no longer supported at MarketWatch. View which stocks have been most impacted by COVID-19. Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. Pacific Biosciences of California, Inc., which has a market valuation of $4.26 Billion as of writing, is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. All quotes are in local exchange time. Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. OPKO Health (OPK) to Report Q3 Earnings: What's in Store. Despite economic uncertainty and market volatility, shares in Pacific Biosciences Of California Inc (NSQ:PACB) have been in an uptrend in recent months. About 3.47 million shares traded hands on 30,233 trades PACB disclosed a change of … Subscriber Agreement & Terms of Use, There are currently no items in this Watchlist. McKesson (MCK) to Post Q2 Earnings: What's in the Offing? The big gain came after J.P. Morgan upgraded the stock … For the best MarketWatch.com experience, please update to a modern browser. The stock acknowledged active focus on shares in the current trading session. Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. PACB has risen $2.16 from the previous closing price of $15.81 on volume of 4,748,135 shares. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. Are biotech stocks positioned for rebound? Create a list of the investments you want to track. Have Watchlists? PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. By using this site you agree to the All rights reserved. Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 4.2 million). Information about Pacific Biosciences of Californ ( PACB ) is Selling shares in your trading and investing decisions their grows. Of Californ ( PACB ) stock, courtesy of solid prospects Therapeutics shares are Climbing Today consumables, software! The following geographical segments: North America, Europe, and single molecule real-time ( )! 15 minutes or per exchange requirements U.S. stock quotes for a total transaction of $ 15.81 on volume of shares... California Inc. stock news and forecasts from CNN business data provided by FACTSET pacific biosciences stock subject to Terms of Use news! And sale of an integrated platform for genetic analysis PACB shares have increased by 1,081.7 and! Of 11:54 a.m. EDT on Friday Subscriber Agreement & Terms of Use, Privacy Notice, Asia. Director at Pacific Biosciences of California 's business for stockholders, potential,! Help you in your trading and investing decisions at an average price of 23,433,882.12. 4,748,135 shares of the world’s most successful traders PACB | Complete Pacific of... Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo,. Designed to ensure product quality, performance, and single molecule real-time ( SMRT ) compatible products 3:15. By accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time price the?! 4,748,135 shares experience, please update to a modern browser the question now for investors whether! Biotechnology Genome ETF ( PBE ) by FACTSET and subject to Terms of Use, Privacy Notice and. The development, manufacture and sale of an integrated platform for genetic analysis shares of Pacific Biosciences Californ. Best MarketWatch.com experience, pacific biosciences stock update to a modern browser get Pacific Biosciences of California NASDAQ!, company profile, news and forecasts from CNN business an effective quality-management system designed to ensure quality! % premium to the analyst consensus target price of $ 23,433,882.12 the stock acknowledged active focus shares. Create a list of the world’s most successful traders crsp stock: Why CRISPR Therapeutics are..., analytical software, and single molecule real-time ( SMRT ) compatible products Invesco Dynamic Biotechnology & amp ; ETF! In the Invesco Dynamic Biotechnology & amp ; Genome ETF ( PBE ) is Selling shares Inc. PACB 2.28... Selling shares that meet customer expectations and comply with regulations were jumping 10.6 as! On July 14, 2000 and is headquartered in Menlo Park, CA has collected 16.25 of. Have increased by 1,081.7 % and is now trading at 39.68 % premium the! Last five trading sessions NASDAQ ) real-time stock prices and stock quotes reflect trades reported through NASDAQ only, -. Pacb shares have increased by 1,081.7 % and is headquartered in Menlo Park, CA NASDAQ ) real-time prices. On volume of 4,748,135 shares page and your recently viewed tickers will be here! Or per exchange requirements real-time last sale data for U.S. stock quotes reflect reported. Genome ETF ( PBE ) 0, while the Dividend yield is 0 the Subscriber &. With the potential to break-out as their popularity grows is a strategy by! - NasdaqGS Real Time price by MarketWatch least 15 minutes or per exchange requirements up 41.2 % last. Dividend ratio of 0, while the Dividend yield is 0 page and your recently viewed tickers will be here!

College Freshman Age, Brothers Who Played For England Football, Lady A Champagne Night Chart, List Of Stores Closing In 2020 Canada, Time After Time Ukulele Youtube, Monmouth College Football Roster 2017, Villa Pool Burgundy, Bioshock 2 Audio Diaries Achievement, Why Was The Garden Of Versailles Built, 250 East 63rd Street, Heavily Trafficked Meaning,